Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status
10.1186/s12885-015-1191-3
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
BioMed Central
2016
|
| Online Access: | http://scholarbank.nus.edu.sg/handle/10635/127278 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-127278 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-1272782023-10-31T08:05:41Z Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status Chong, Dawn qingqing Toh, Xinyi Ho, Ivyaw Sia, Kianchuan Newman, Jennifer P. Yulyana, Yulyana Ng, Waihoe Lai, Sianghui Ho, Mac M F Dinesh, Nivedh Tham, Cheekian Lam, Yeng Po Paula DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE 10.1186/s12885-015-1191-3 BMC Cancer 15 1 2016-09-09T00:48:41Z 2016-09-09T00:48:41Z 2015 Article Chong, Dawn qingqing, Toh, Xinyi, Ho, Ivyaw, Sia, Kianchuan, Newman, Jennifer P., Yulyana, Yulyana, Ng, Waihoe, Lai, Sianghui, Ho, Mac M F, Dinesh, Nivedh, Tham, Cheekian, Lam, Yeng Po Paula (2015). Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status. BMC Cancer 15 (1). ScholarBank@NUS Repository. https://doi.org/10.1186/s12885-015-1191-3 14712407 http://scholarbank.nus.edu.sg/handle/10635/127278 000353319500001 BioMed Central |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| description |
10.1186/s12885-015-1191-3 |
| author2 |
DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
| author_facet |
DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE Chong, Dawn qingqing Toh, Xinyi Ho, Ivyaw Sia, Kianchuan Newman, Jennifer P. Yulyana, Yulyana Ng, Waihoe Lai, Sianghui Ho, Mac M F Dinesh, Nivedh Tham, Cheekian Lam, Yeng Po Paula |
| format |
Article |
| author |
Chong, Dawn qingqing Toh, Xinyi Ho, Ivyaw Sia, Kianchuan Newman, Jennifer P. Yulyana, Yulyana Ng, Waihoe Lai, Sianghui Ho, Mac M F Dinesh, Nivedh Tham, Cheekian Lam, Yeng Po Paula |
| spellingShingle |
Chong, Dawn qingqing Toh, Xinyi Ho, Ivyaw Sia, Kianchuan Newman, Jennifer P. Yulyana, Yulyana Ng, Waihoe Lai, Sianghui Ho, Mac M F Dinesh, Nivedh Tham, Cheekian Lam, Yeng Po Paula Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status |
| author_sort |
Chong, Dawn qingqing |
| title |
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status |
| title_short |
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status |
| title_full |
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status |
| title_fullStr |
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status |
| title_full_unstemmed |
Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status |
| title_sort |
combined treatment of nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the egfr mutation status |
| publisher |
BioMed Central |
| publishDate |
2016 |
| url |
http://scholarbank.nus.edu.sg/handle/10635/127278 |
| _version_ |
1781790332599402496 |